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Abstract
We developed decision rule sets for Lipid Data Analyzer (LDA; http://genome.tugraz.at/lda2), 
enabling automated and reliable annotation of lipid species and their molecular structures in high-
throughput data from chromatography-coupled tandem mass spectrometry. Platform independence 
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was proven in various mass spectrometric experiments, comprising low- and high-resolution 
instruments and several collision energies. We propose that this independence and the capability to 
identify novel lipid molecular species render current state-of-the-art lipid libraries now obsolete.
Lipidomics is a rapidly evolving scientific discipline that provides high-throughput data for 
elucidating lipid structure, metabolism and dynamics at cellular and tissue-level scales1,2. 
Liquid chromatography-linked tandem mass spectrometry (LC-MS/MS) enables analyses 
including simultaneous high precision quantitative measurements of hundreds to thousands 
of lipids in complex mixtures3. Such “profiling” can be carried out at six levels of structural 
information: (i) the lipid subclass level, (ii) bond type level, (iii) fatty acyl level, (iv) fatty 
acyl position level, (v) fatty acyl/sphingoid base structure level and (vi) the LIPID MAPS 
level; the latter adheres to full structural elucidation including double bond location and 
geometry4. Throughout this paper the term lipid species refers to lipid subclass including 
bond type level which identifies lipids by numbers of carbons and double bonds of 
constituent fatty acyl and/or alkyl/1-alkenyl chains (e.g. PI 38:4). The term lipid molecular 
species corresponds to fatty acyl level (e.g. PI 20:4_18:0) and/or fatty acyl position level 
(e.g. PI 18:0/20:4), in which structural information such as identification of constituent 
chains and determination of their respective regio-selectivities at the glycerol backbone is 
obtained. In these approaches for lipid profiling, automated lipid annotation relies currently 
on spectral libraries5–7. However, variables such as the type of mass spectrometer, the 
collision energy applied, the type of adduct ion, and the charge state, all cause substantial 
variation in the MS/MS spectra of lipid molecular species (Fig. 1).
Thus, matching of spectral data to experimentally- or in silico-generated spectral libraries is 
problematic for the following reasons: (i) it is not possible to detect novel lipid molecular 
species which are absent from spectral libraries (with novel acyl and/or alkyl/1-alkenyl 
constituents, or an unusual sn-position); (ii) it is challenging to obtain decisive information 
from low-abundance signals (e.g. fatty acyl and/or alkyl/1-alkenyl chain fragments from 
phospholipids in positive ion mode), because the matching algorithms are geared mainly 
toward higher-intensity signals; (iii) the sn-positions of fatty acyl and/or alkyl/1-alkenyl 
constituents are extremely difficult to determine, because general matching algorithms are 
not designed to discriminate the intensity relationships of low-abundance fragments that 
would reveal stereochemistry; (iv) it is not possible to discriminate between isobaric lipid 
species and between structural isomers of lipid molecular species; (v) users are, to a certain 
extent, precluded from setting up their own spectral libraries tailored to their platform 
because of the impracticality of having to generate thousands of in silico MS/MS spectra for 
each adduct of each single lipid subclass.
Here we describe a universal and flexible solution to the above limitations by introducing 
decision rule sets for lipid subclasses/adducts, including an algorithm to apply these rules for 
identification of lipid species and lipid molecular species. This enables lipid annotation in 
high-throughput data derived from chromatography-coupled tandem mass spectrometry. The 
tool, which we call Lipid Data Analyzer (LDA), adapts not only to specific parameters of the 
various MS platforms, but also to changes in collision energies and to different adduct ions. 
Consequently, lipid annotation is based on well-defined fragments (fragment rules) and their 
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intensity relationships (intensity rules), allowing for routine profiling of known lipid targets 
and for detection of novel lipids (Online Methods). As such, the software flexibly 
accommodates differences in fragmentation behavior. Importantly, the decision rule sets 
allow identification of fatty acyl and/or alkyl/1-alkenyl constituents and determination of 
their respective sn-positions at the glycerol backbone (in the case of co-eluting regio-
isomers, the assignment is based on the more abundant regio-isomer), even with low-
abundance lipid molecular species, as well as the definition of fragments from isobaric/
isomeric lipid subclasses for their differentiation.
The basis for the fragment rules is derived from available information about lipid 
fragmentation8. To gather further evidence supporting the reliability of the fragments and to 
establish the intensity rules, we conducted three control experiments containing lipid 
standards of known constituent fatty acyl and/or alkyl/1-alkenyl chains including their 
respective sn-positions and one biological experiment on the lipidome of murine liver 
samples. In total, we performed more than 600 LC-MS/MS runs on eight different MS/MS 
platforms (AB Sciex, Agilent Technologies, Thermo Scientific, and Waters – Supplementary 
Table 1, Supplementary Note 1), summarized as follows:
• In control experiment 1, which included 78 non-isobaric/non-isomeric standard 
lipids from 14 lipid subclasses (Supplementary Table 2), we generated respective 
decision rule sets for each lipid subclass/adduct and successfully validated the 
algorithm in MS/MS spectra. This pertained to the identification of the 
stereochemistry of lipid molecular species as well.
• In control experiment 2, with eight isomeric lipid molecular species 
(Supplementary Table 3), we verified the ability of the algorithm to discriminate 
between isomeric species from different lipid subclasses/adducts in MS and 
MS/MS spectra (Supplementary Table 4).
• In control experiment 3, with 16 structural isomers of lipid molecular species 
originating from different subclasses mixed at various concentrations 
(Supplementary Table 5), we demonstrated that the algorithm appropriately 
assigned the respective structural isomers (Supplementary Tables 6 and 7).
• The biological experiment with the lipidome of murine liver, allowed us to 
confirm the capability of LDA to deal with complex biological samples. The 
algorithm clearly identified low-abundance species (Supplementary Fig. 1), 
isobaric species and structural isomers contained in these samples (see http://
www.ebi.ac.uk/metabolights/MTBLS396). This approach also allowed the 
identification of 109 novel lipid molecular species and 6 novel regio-isomeric 
species (Supplementary Table 8 and Supplementary Fig. 2); we consider a lipid 
molecular species as “novel” if it is neither present in LIPID MAPS Structure 
Database9, ChEBI10, CyberLipid (http://www.cyberlipid.org), HMDB11, nor 
YMDB12. Details about identified lipid molecular species on the various 
platforms, including a cross-platform comparison, are given in Supplementary 
Tables 9 and 10.
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We used data from control experiment 1 and the biological experiment (acquired on Orbitrap 
Velos Pro in CID mode and on 4000 QTRAP with collision energy settings of +50% and 
-50%, and +45eV and -45eV, respectively) to verify our approach and to benchmark the 
LDA algorithm against the state of the-art in silico library LipidBlast7 (Online Methods and 
Supplementary Note 2). Compared with LipidBlast, LDA typically identified considerably 
more lipid (molecular) species with higher confidence (Table 1 and Supplementary Tables 
11-13). Data at lipid species level revealed that ‘stringent’ LipidBlast conditions identified 
only a third of the lipid species identified by LDA (n=1041; 97% of 1077 manually 
identified species). When we used ‘relaxed’ LipidBlast settings, the number of correctly 
identified lipid species increased at the cost of drastically reduced positive predictive values. 
More dramatic were the findings at lipid molecular species level, for which LDA identified 
an impressive 2862 (80% of 3567) lipid molecular species (see Table 1), underlining its 
power to discriminate lipid structural details. In addition to its broader scope to 
quantitatively analyze lipid molecular species13 even at low abundance (Supplementary Fig. 
1), a further important advantage of LDA is the greatly improved detectability of 
unanticipated fatty acyl and/or alkyl/1-alkenyl combinations (Supplementary Table 8 and 
Supplementary Fig. 2). Moreover, LDA unambiguously assigned the sn-positions for almost 
all standards (positive ion mode: 104/110; negative ion mode 105/105), whereas LipidBlast 
using ‘relaxed’ settings consistently reported an erroneous positional isomer in addition to 
the correct species (http://www.ebi.ac.uk/metabolights/MTBLS397). In the case of co-
eluting regio-isomeric lipid molecular species, the assignment is based on the more abundant 
regio-isomer (Supplementary Fig. 3 and 4); chromatographic approaches exist to solve this 
issue14.
Of note, sophisticated software programs for lipid identification in direct infusion (shot-gun) 
MS have been developed15–18; however, unlike LDA, they do not support chromatography-
linked approaches, which are now frequently used in lipidomics19. The LDA approach 
correctly identifies isobaric and isomeric lipids, and structural isomers, enabling their use as 
diagnostic markers in routine analyses on the one hand, and as key indicators of healthy 
versus aberrant metabolism on the other. Owing to the high sensitivity attainable with LDA, 
information derived from low-abundance fragments (e.g. in positive ion mode) is now made 
accessible and can be converted into lipid structures. Moreover, the software reports 
structural annotations based solely on spectral evidence (Supplementary Fig. 5 and 6) and 
avoids misleading structural overdetermination20.
LDA offers platform independence and utmost flexibility by circumventing the need for 
experimental and in silico spectral libraries. Indeed, users can easily adapt existing decision 
rule sets or generate new ones (even for other metabolite classes), as LDA features a 
graphical user interface for such rule definition that provides direct visual feedback on 
acquired spectra (Online Methods and Supplementary Fig. 7). Generally, further decision 
rule set development should be based on measured standards and subsequent validation in 
pertinent biological settings, but can also be performed on biological data directly, if the 
lipid subclasses/adducts are sufficiently separated by chromatography.
LDA currently offers highly reliable decision rule sets for various adducts of 14 major lipid 
subclasses acquired using platforms from multiple major instrument vendors. LDA 
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annotations reflect the level of structural details inherent to the analyzed spectra, while 
avoiding reporting of unsubstantiated structural details. The simplicity of defining and 
handling decision rule sets allows for easy application of LDA by bioinformaticians and 
mass spectrometrists.
Online Methods
We provide first the bioinformatics background including explanations for how data are 
processed by LDA via “decision rule sets”, we illustrate then the versatility of LDA through 
various application notes.
Decision rule sets
MS/MS spectra of lipids vary greatly, depending on the type of mass spectrometer used, the 
collision energy applied, the adduct ions and charge state. Taking these factors into account, 
we developed flexible decision rule sets that enable automated annotation of lipids in the 
generally accepted format4 at multiple levels of structural detail (Supplementary Fig. 5 and 
6).
A decision rule set for a lipid subclass/adduct consists of the section ([GENERAL]), 
pertaining to general lipid subclass information, and of the three sections ([HEAD], 
[CHAINS], and [POSITION]), corresponding to information concerning the structural 
details. The latter three sections do not apply to subclasses/adducts lacking a head group or 
chain fragment. In these three sections, fragment rules and intensity rules reflect the pattern 
of MS/MS spectra, as we exemplify for deprotonated diacylglycerophosphoinositol (PI) in 
Supplementary Figure 8. This figure demonstrates fragment rules (‘!FRAGMENTS’) 
consisting of an arbitrary name, a chemical formula (for m/z value calculation), the charge 
state, the MSn level where the fragment might be observed (‘2’ corresponds to MS/MS), and 
whether the presence of a fragment is required for positive identification at a certain 
structural level. Moreover, the parameter ‘formula’ allows for the placeholder 
‘$PRECURSOR’ (corresponding to the mass of the precursor) to define neutral losses. 
‘$CHAIN’ designates any possible fatty acyl chain, and ‘$ALKYLCHAIN’/
‘$ALKENYLCHAIN’ any alkylated/1-alkenylated forms, respectively. Previously defined 
fragments can be reused (e.g. section ‘[CHAINS]’). The parameter ‘mandatory’ is set to true 
for characteristic fragments, such as the neutral loss of the phosphoethanolamine head 
fragment (neutral loss of 141 Da) in spectra of protonated 
diacylglycerolphosphoethanolamines (PE). The parameter ‘mandatory’ is set to false for 
fragments observed infrequently. Even though the presence of such fragments is not 
essential to any annotated structural level, usage of infrequent fragments in intensity rules 
considerably improves the reliability of annotations. A third option for this parameter is 
other, which designates fragments originating from isobaric or isomeric lipid species not 
belonging to the lipid subclass of the rule set. This is used to discard false positive 
identifications.
Intensity rules (‘!INTENSITIES’) consist of ‘equation’ parameters representing allowed 
intensity relationships of fragments, and the parameter ‘mandatory’. The parameter 
‘equation’ utilizes any previously defined fragments, including a placeholder called 
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‘$BASEPEAK’, to define a minimum intensity for fragments. Furthermore, an optional 
number in square brackets defines the sn-position of the fragment. For the parameter 
‘mandatory’, only true or false is allowed. The effect of this parameter depends on the 
section in which it is used, as will be discussed in the following paragraphs.
The algorithm processes the sections in the aforementioned order. A decision rule set is 
applied on a consolidated spectrum, i.e., a spectrum consisting of the sum of denoised 
spectra (Supplementary Note 3) within a detected MS1 peak. Quantification of MS1 peaks 
and removal of isotopic peaks is performed as described by Hartler et al.13. Moreover, for 
lipid species verified by reverse phase LC-MS/MS, LDA offers a non-linear fitting approach 
to predict retention times of lipid species determined by MS1 only. This allows to remove 
peaks with implausible retention times (Supplementary Note 4).
Starting with the [HEAD] section, the algorithm calculates the m/z values of the fragments 
and interrogates the consolidated spectrum for their presence (Supplementary Fig. 9a). 
When mandatory fragments cannot be detected in the spectrum, the algorithm discards the 
associated MS1 peak. Otherwise, fragment intensities are checked for compliance with the 
intensity rules (Supplementary Fig. 9b). Again, if a mandatory intensity rule is not fulfilled 
in the [HEAD] section, the MS1 identification will be discarded. [HEAD] section rules are 
the primary check for verification of a lipid subclass/adduct. Note that in cases where 
subclasses/adducts lack head group specific fragments (e.g. ammoniated triacylglycerols), 
false positive MS1 identification will be discarded by the spectrum coverage. The spectrum 
coverage is controlled by an adjustable threshold for the percentage of annotated fragment 
intensities.
For the [CHAINS] section, the algorithm computes all possible chain combinations 
pertaining to the total number of carbon atoms and double bonds of the particular lipid 
species; e.g., PI 18:1_20:3 is appropriate for PI 38:4. The same procedure as for head group 
is applied for each potential chain (Supplementary Fig. 10 shows an example for PI 38:4 
containing a 20:4 residue). The algorithm will typically report chain combinations only if all 
chains in the combination comply with the decision rules. However, there are subclasses/
adducts where acyl- or alkyl/1-alkenyl chains at certain positions show low-abundance 
fragments only. An example is deprotonated 1-(1Z-alkenyl),2-
acylglycerophosphoethanolamine, where the deprotonated alkenyl chain is of extremely low 
intensity (due to resonance stabilization of the carboxylate anion). For such cases, a 
parameter is available in section [GENERAL] to allow acceptance of a certain combination 
with only one verified chain. If low/high abundance chains comply with the rules, the 
algorithm will advance to the [POSITION] rules.
[POSITION] rules consist of intensity comparisons of previously defined fragments 
(Supplementary Fig. 11a). If mandatory intensity rules are defined, all of them must be 
fulfilled for sn-position assignment, whereas for optional rules (‘mandatory’ false), a 
majority already suffices for an assignment (Supplementary Fig. 11b). This approach is 
preferable, because in some cases the most reliable position information is derived from 
low-abundance, rare fragments. If these fragments are present, they are decisive by a 
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mandatory intensity rule; otherwise, position assignment is based on less reliable, optional 
intensity rules.
The decision rule sets and the algorithm for their interpretation allow for utmost flexibility, 
such as inclusion of isotopically labeled standards (used in TG rule development – 
Supplementary Table 2), and even for the detection of co-eluting lipid molecular species, 
which is encountered frequently (Supplementary Fig. 12). Although the rules use a syntax 
easily comprehensible for mass spectrometrists, we recognized the need for adapting and 
extending the existing rules provided thus far, and for generating rules for further lipid 
subclasses/adducts. Consequently, we implemented a graphical user interface for rule 
definition which provides direct visual feedback on acquired spectra (Supplementary Fig. 7).
Experiments carried out for rule development and verification
The experimental execution is described in detailed protocols presented in Supplementary 
Note 1 and Supplementary Table 1. Data obtained are discussed in the main text and shown 
in Supplementary Tables 2 to 10, and Supplementary Figure 13. No statistical testing was 
applied. Further information is provided in the Life Sciences Reporting Summary published 
alongside this paper. Detailed data and further details on results are available online (see 
“Data availability” at the end of this section).
Application note 1
Collision energies in mass spectrometry are considered optimal for a subclass/adduct when 
both the head group and chain fragments are equally well represented. Since these energies 
vary depending on the subclass/adduct, as a tradeoff we selected energies which delivered 
the best overall result with the platform we used for the given lipidome in control 
experiment 1.
Application note 2
The basic fragment rules are based on published results8,21. They were adapted and 
extended by visual inspection of spectra from control experiment 1 and biological data. We 
determined detectable fragments, identified mandatory fragments, derived intensity rules, 
and extracted decisive differences for many isobaric/isomeric subclasses/adducts. Further, 
we determined intensity relationships characteristic for sn-position assignment. Finally, we 
found novel fragment ion relationships, such as the relative intensity of the sodiated form of 
a carboxylated chain fragment that allowed for differentiation between 1,2- and 1,3-
diacylglycerols at optimal collision energies, and demonstrated the software’s capability to 
distinguish regio-isomers under certain chromatographic conditions (Supplementary Fig. 4 
and Supplementary Table 14).
We defined more than 1,000 decision rule sets for lipid subclasses/adducts for various MS 
platforms and experimental conditions. These decision rule sets cover the major lipid 
subclasses and mass spectrometers commonly used today and will serve as a point of entry 
for investigators unfamiliar with lipid data analysis. The direct visual feedback particularly 
provides an easy introduction to fragmentation patterns of lipids. Importantly, decision rule 
sets developed are provided along with software for the algorithm, which can be downloaded 
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from http://genome.tugraz.at/lda2. In addition, raw data, results of detailed analysis, 
comments about information content that can be derived from the various adduct ions, and 
suggestions about optimal collision energies for subclasses/adducts are available.
Application note 3
In general, isobars or isomers from different lipid subclasses/adducts are 
chromatographically separated only slightly, and such separation cannot be judged from 
MS1 spectra. Thus, we expanded our algorithm to separate MS1 peaks consisting of pairs of 
isobaric or isomeric subclasses/adducts. The algorithm extracts ion chromatograms from the 
absolute intensities of distinct fragments belonging solely to one or the other species, and 
computes the retention time (RT) maxima of either lipid species. A weighted mean (based 
on abundances of the fragments) is used to estimate the RT of such maxima. If there is at 
least one MS/MS scan between the maxima, or the maxima are in the vicinity of two 
different adjacent MS/MS spectra (in the range of 20% of the distance between the spectra), 
the mean of the two RTs is defined as the position of the split of the MS1 peak. If the RT 
cannot be determined using absolute intensities, the same procedure is applied to relative 
intensities. If this also fails, the MS1 peak intensity is distributed according to the intensities 
of the distinct fragments. However, for isobars/isomers of different subclasses/adducts (e.g. 
protonated PC and PE), this approach is highly inaccurate and should be avoided, because 
intensities of the fragments typically do not reflect the MS1 intensities. To verify this, we 
pooled lipid standards of PC, PE, LPC, and LPE subclasses, where isomeric species can be 
observed as protonated and sodiated adduct ions, and deliberately worsened chromatography 
parameters to generate overlapping MS1 peaks (Supplementary Fig. 14). This experiment 
revealed that a successful peak split primarily depends on the availability of MS/MS scans. 
Whereas successful splits were frequent for PC/PE species and for platforms with high 
MS/MS scan rates, less well-separated LPC/LPE species were often left unsplit 
(Supplementary Table 4). Nonetheless, the presence of either isomer was detected in almost 
all cases (97%).
Application note 4
LDA detects and assigns structural isomers of the same lipid subclass/adduct from a shared 
MS1 peak, whereupon the abundance of the MS1 peak is split according to intensities 
detected in the MS/MS spectra (Supplementary Fig. 12). To this end we determined 
detection rate, accuracy, and variability of results obtained from experiments with structural 
isomers mixed in concentration ratios up to 1:20. As expected, results varied depending on 
MS ion mode and ionization mode (Supplementary Tables 6 and 7, and Supplementary Fig. 
13). Whereas negative ion mode generally produced results with low coefficients of 
variation, positive ion mode led to results with high coefficients of variation due to low 
abundance chain fragments. In fact, at higher concentration ratios, chain fragments of low-
abundance species are not detectable at all. An interesting showcase for a potential pitfall 
due to a low MS/MS sampling rate was found for PE acquired on QTOF in positive ion 
mode. Whereas chromatographically separated isomeric PE 36:4 species produced excellent 
lipid molecular species ratios, mixed PE 36:2 species produced much higher abundances for 
PE 18:0/18:2 in comparison to PE 18:1/18:1. The reason is that, in this particular case, the 
QTOF instrument reported MS/MS spectra only at the end of the MS1 peak; therefore, the 
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slightly earlier eluting PE 18:1/18:1 yielded lower 18:1 chain intensities. Interestingly, chain 
fragments of some species reflect the true ratios quite well (e.g. PC 34:0 in negative ion 
mode), while others usually underestimate the true ratio (e.g. PE 36:4). Generally, to derive 
absolute intensities of pairs of structural isomers from the same MS1 peak, calibration 
curves are strongly recommended.
Application note 5
In a benchmark test of LDA versus LipidBlast7, we used data from both the first control 
experiment and the biological experiment, both acquired on Orbitrap Velos Pro in CID 
+50% and -50%, and on 4000 QTRAP +45 eV and -45 eV, respectively. For LipidBlast 
evaluation, we used the recommended MSPepSearchGUI (http://peptide.nist.gov/software/
ms_pep_search_gui/MSPepSearch.html). The same m/z tolerances were applied in both 
LDA and LipidBlast. The specificity and sensitivity of LipidBlast depend on a so called 
matching factor22, a value ranging from 0-999. Using the default setting of 450 for the 
matching factor, many lipid standards in control experiment 1 were not detected. 
Consequently, the matching factor was lowered to 10, in which case LipidBlast detected 
almost all of the lipid standards in negative ion mode. Further reduction did not improve the 
sensitivity of LipidBlast. In positive ion mode, irrespective of the matching factor setting, 
LipidBlast was not able to identify as many lipid molecular species as was LDA. Details 
about the LipidBlast parameters are given in Supplementary Note 2. In this benchmark, we 
used only lipid subclasses/adducts that both LDA and LipidBlast are able to detect. Correct 
assignment of lipid species and lipid molecular species identified in liver lipidomes was 
verified by manual inspection of the spectra, and by aligning them with the respective 
retention time data23.
Code availability and technical details
The algorithm presented is embedded in the Java software package LDA (version 2.5.2) 
which performs MS1 peak deconvolution13, and supports several operating systems such as 
Windows, MacOS, Linux and other Unix-based systems. Calculations were performed on a 
64-bit Windows 7 desktop PC equipped with an Intel Core i7-2600 CPU at 3.4GHz and 
16GB RAM under Windows 7. Decision rule sets were tested on the following MS/MS 
platforms: 4000 QTRAP and QTRAP 6500 from AB Sciex; G6550A QTOF from Agilent 
Technologies; Orbitrap Elite, Orbitrap Velos Pro in CID and HCD mode, and Q Exactive 
from Thermo Fisher Scientific; SYNAPT G1 HDMS QTOF from Waters. The primary raw 
data format is mzXML24; however, the software allows for direct processing of vendor 
formats from AB Sciex, Agilent Technologies, Bruker Daltonics and Thermo Fisher 
Scientific by an integrated version of msConvert25, as we obtained permission for 
redistribution of vendor-provided libraries from respective mass spectrometer manufacturers. 
For Waters “.raw” directories, installation of Mass++ (http://masspp.jp) is required. LDA 
including the decision rule sets is freely available from (http://genome.tugraz.at/lda2). The 
source code is released under a GNU GPL v3 license and is available from https://
github.com/ThallingerLab/LDA2/releases/tag/2.5.2.
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Data availability
Data and analysis of results from control experiments 1-3, the biological experiment, 
LipidBlast benchmarking, HCD characterization, and detection of regio-isomers are 
available from the MetaboLights26 repository with accession numbers MTBLS394 (Control 
experiment 1), MTBLS391 (Control experiment 2), MTBLS398 (Control experiment 3), 
MTBLS396 (Biological experiment), MTBLS397 (Benchmarking), and MTBLS462 (HCD 
characterization and regio-isomers), respectively. Raw data and results are available from 
authors’ website too (http://genome.tugraz.at/lda2). Detailed data documentation can be 
found in Supplementary Note 5.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Tandem mass spectra of lipid molecular species depend on platform and collision energy. 
Spectra of deprotonated PI 18:0/20:4 from two platforms and two collision energy settings 
are shown: (a) Orbitrap Velos Pro, CID mode, 30 %, precursor m/z 885.545, damping gas 
He; (b), 4000 QTRAP, CID mode, 30 eV, precursor m/z 885.93, collision gas N2; (c) 
Orbitrap Velos Pro, CID mode, 60 %, precursor m/z 885.549, damping gas He; (d) 4000 
QTRAP, CID mode, 60 eV, precursor m/z 885.85, collision gas N2.
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Table 1
Sensitivity and positive predictive value (PPV) of LDA and LipidBlast (LB) in positive ion mode based on 
data acquired on Orbitrap Velos Pro in CID mode. LDA outperforms the in silico library approach of 
LipidBlast with matching factors 450 (stringent) and 10 (relaxed). The lipidome of murine liver samples was 
determined five times. “Total lipid (molecular) species” in the column headings below represent the sum of all 
species manually identified in the five MS runs.
Total lipid species identified:
1077
Total lipid molecular species identified:
3567
LDA LB 450 LB 10 LDA LB 450 LB 10
Sensitivity (%)a 97 36 85 80 15 57
PPV (%)b 97 91 70 92 91 58
aSensitivity: percent of total species identified by the software;
b
Positive predictive value: percent of correct identifications.
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